Spacs have pulled in billions of dollars from investors over the past couple of years. But as the FT’s Ortenca Aliaj reports, they’ve also attracted intense scrutiny from regulators. Of particular concern has been the fast-track route to public markets offered by Spacs, as well as some optimistic revenue projections. So, where does that leave the Spacs market?
Activist investors have had a quiet year, thanks to Covid-19. Even a group of investors renowned for their aggressive tactics were reluctant to publicly attack companies reeling from the impact of a global pandemic.
Due Diligence’s James Fontanella-Khan, US corporate finance and deals editor, explains why established companies from brick and mortar retailers to broadcasters are taking risky bets on big acquisitions.
With healthcare providers turning to digital to meet consumer demands, an increasing convergence of healthcare and tech companies could restore M&A activity for 2019. But is this emerging healthtech sector immune to global uncertainty?
FT Channels, a partnership destination that combines impactful and enriching multimedia content to spark curiosity and encourage discovery. Each vertical brings expert insights from the Financial Times and our Partners into the most pressing issues of our time.
FT Big Deal is a video channel analysing the fast-moving world of M&A, illuminating the trends behind the complex global transactions and how to unlock value from acquisition deals. The channel alternates between independent reporting from FT journalists and expert commentary from law firm Baker McKenzie.